Citation Tools

Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

Download to a citation manager

Cite this article as:
Cid MC, Unizony SH, Blockmans D For the KPL-301-C001 Investigators, et al
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial